Tim Demuth - May 13, 2022 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PIRS)

Role
Chief Medical Officer
Signature
/s/ Ahmed Mousa, Attorney-in-Fact
Stock symbol
PIRS
Transactions as of
May 13, 2022
Transactions value $
$10,260
Form type
4
Date filed
5/16/2022, 08:19 PM
Previous filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PIRS Common Stock Purchase $10.3K +6K $1.71* 6K May 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Purchase price was 1.65 Euros per share which was converted into dollars using the noon buying rate of 1.00 Euro to $1.03745 based on information provided on May 13, 2022 via Xignite.